drugset / Trial / NCT01458327
Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial
NaSingle-groupOpen-labelTreatment
Summary
This study will consist of a single session of MDMA-assisted therapy with a full dose of MDMA for people who took part in a study of MDMA-assisted therapy in people with posttraumatic stress disorder (PTSD) whose PTSD symptoms returned to higher levels at least a year after the first MDMA sessions. The single session will be performed by the same pair of therapists who performed the sessions in the first study. People will have a preparatory session, the MDMA-assisted session and three non-drug sessions afterward. Their PTSD symptoms and symptoms of depression will be measured at the start of this study and two and 12 months after the session.
Timeline
- Start
- 2010-12-15
- Primary completion
- 2014-06-27
- Completion
- 2014-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midomafetamine | Unknown | 125 mg | — |